Available in both injectable and oral forms, semaglutide mimics the hormone GLP-1, reducing appetite and supporting lasting weight loss
Cells at 20 ~ 30% confluency were transfected with 3 g pcDNA3.3-dsRed/Sabin1-P1 or pcDNA3.3-dsRed/Mahoney-P1 formulated with Lipo3000 transfection reagent (Invitrogen), and 2 g pcDNA3.3-T7 and 2 g pT7-Replicon-eGFP were co-transfected the next day
Reductions of this magnitude are rare in addiction medicine and what's remarkable is that the finding came from drugs initially designed for diabetes, later repurposed for obesity and never intended to treat addiction
However, avoid jumping to high fiber intake immediately
Age-related comorbidities (metabolic syndromes) such as, obesity, T2DM, asthma, and CVD, could also increase severity and mortality in elderly COVID-19 patients
Epithalon research findings to date are summarized below